Study of DA-007 for preventing chemotherapy hair loss
Part of Cancer, Skin clinical trials.
This trial tests a treatment called DA-007 to see if it can prevent hair loss caused by chemotherapy in people with early-stage breast cancer. If you are about to start chemotherapy with taxane or anthracycline drugs, this study might help you keep your hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage 1 or stage 2 breast cancer
- You are between 18 and 65 years old
- You are scheduled to get at least 4 cycles of taxane or anthracycline chemotherapy but have not started yet
- You do not have any scalp conditions like psoriasis, dermatitis, or folliculitis
- You are not currently wearing a wig
- You do not take MAO inhibitor medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This early-phase trial tests how a new scalp treatment (DA-020) is absorbed and processed in healthy women. It aims to see how the medicine behaves in the body and if it is safe.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
This trial tests whether minoxidil (a hair-regrowth medication) alone or combined with red-light therapy can help hair grow back after breast cancer chemotherapy. The goal is to help patients recover from chemotherapy-induced hair loss.
Hear when a new Chemotherapy Induced Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.